{"id": "NgV8n_wAAAAJ", "citedby": 25016, "citedby5y": 6961, "hindex": 76, "hindex5y": 42, "i10index": 144, "i10index5y": 99, "coauthors": [{"id": "zwA0LZwAAAAJ", "name": "Galinos Fanourakis", "affiliation": "National and Kapodistrian University of Athens"}, {"id": "UAZW70IAAAAJ", "name": "Towia Libermann", "affiliation": "Beth Israel Deaconess Medical Center and Harvard Medical School"}, {"id": "KXkTD68AAAAJ", "name": "Vassiliki Kotoula", "affiliation": "Dept of Pathology, School of Medicine, AUTH"}, {"id": "QWgAm54AAAAJ", "name": "Bert W. O'Malley", "affiliation": "Baylor College of Medicine"}, {"id": "OQbyeDgAAAAJ", "name": "Sue Anne Chew", "affiliation": "Assistant Professor of Health and Biomedical Sciences, University of Texas Rio Grande Valley"}, {"id": "rKvm_jEAAAAJ", "name": "Mantzoros Christos", "affiliation": "Harvard"}, {"id": "nKV_V78AAAAJ", "name": "Kimal Rajapakshe", "affiliation": "Baylor College of Medicine"}, {"id": "8dpZ-5QAAAAJ", "name": "gareth morgan", "affiliation": "UAMS"}, {"id": "R1adZdgAAAAJ", "name": "George MASTORAKOS", "affiliation": "National and Kapodistrian University of Athens, Medical School"}, {"id": "4R7_wW8AAAAJ", "name": "Chris Sander", "affiliation": "Dana-Farber Cancer Institute, Harvard Medical School, Broad Institute, Memorial Sloan Kettering"}, {"id": "q5RyRCMAAAAJ", "name": "Neal Rosen", "affiliation": "Professor of Pharmacology, Memorial Sloan-Kettering Cancer Center"}, {"id": "qmhO0LEAAAAJ", "name": "Michael Koutsilieris, MD (Athens), Ph....", "affiliation": "Professor of Experimental Physiology, Medical School, National and Kapodistrian University of Athens"}], "name": "Nicholas Mitsiades", "affiliation": "Baylor College of Medicine", "interests": ["Prostate cancer", "Endocrine malignancies", "Cancer", "Drug development", "Translational research"], "cites_per_year": {"2000": 71, "2001": 138, "2002": 292, "2003": 716, "2004": 1030, "2005": 1476, "2006": 1528, "2007": 1656, "2008": 1449, "2009": 1434, "2010": 1367, "2011": 1569, "2012": 1640, "2013": 1760, "2014": 1581, "2015": 1573, "2016": 1377, "2017": 1249, "2018": 1176, "2019": 1140, "2020": 443}, "publications": [{"bib": {"title": "Integrative genomic profiling of human prostate cancer", "year": "2010"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:YsMSGLbcyi4C", "citedby": "2871"}, {"bib": {"title": "NF-\u03baB as a therapeutic target in multiple myeloma", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:u5HHmVD_uO8C", "citedby": "1070"}, {"bib": {"title": "The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:u-x6o8ySG0sC", "citedby": "843"}, {"bib": {"title": "Molecular sequelae of proteasome inhibition in human multiple myeloma cells", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:d1gkVwhDpl0C", "citedby": "841"}, {"bib": {"title": "Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:2osOgNQ5qMEC", "citedby": "760"}, {"bib": {"title": "A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:nVrZBo8bIpAC", "citedby": "726"}, {"bib": {"title": "Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:9yKSN-GCB0IC", "citedby": "703"}, {"bib": {"title": "Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:qjMakFHDy7sC", "citedby": "675"}, {"bib": {"title": "Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-\u03b1 suppression", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:zYLM7Y9cAGgC", "citedby": "635"}, {"bib": {"title": "Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:UeHWp8X0CEIC", "citedby": "613"}, {"bib": {"title": "Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:IjCSPb-OGe4C", "citedby": "570"}, {"bib": {"title": "Activation of NF-\u03baB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Tyk-4Ss8FVUC", "citedby": "551"}, {"bib": {"title": "Biologic sequelae of nuclear factor\u2013\u03baB blockade in multiple myeloma: therapeutic applications", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:W7OEmFMy1HYC", "citedby": "456"}, {"bib": {"title": "TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Y0pCki6q_DkC", "citedby": "451"}, {"bib": {"title": "Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:eQOLeE2rZwMC", "citedby": "448"}, {"bib": {"title": "Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal \u2026", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:WF5omc3nYNoC", "citedby": "395"}, {"bib": {"title": "Antimyeloma activity of heat shock protein-90 inhibition", "year": "2006"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:_FxGoFyzp5QC", "citedby": "362"}, {"bib": {"title": "Molecular sequelae of histone deacetylase inhibition in human malignant B cells", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ufrVoPGSRksC", "citedby": "336"}, {"bib": {"title": "The Akt pathway: molecular targets for anti-cancer drug development", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:LkGwnXOMwfcC", "citedby": "284"}, {"bib": {"title": "Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:0EnyYjriUFMC", "citedby": "284"}, {"bib": {"title": "Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity", "year": "2010"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:RHpTSmoSYBkC", "citedby": "281"}, {"bib": {"title": "Immunomodulatory drug costimulates T cells via the B7-CD28 pathway", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:KlAtU1dfN6UC", "citedby": "271"}, {"bib": {"title": "Total and High-Molecular-Weight Adiponectin in Breast Cancer: In Vitro and in Vivo Studies", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Wp0gIr-vW9MC", "citedby": "254"}, {"bib": {"title": "Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:roLk4NBRz8UC", "citedby": "244"}, {"bib": {"title": "NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:UebtZRa9Y70C", "citedby": "241"}, {"bib": {"title": "Nuclear factor-\u03baB p65 mediates tumor necrosis factor \u03b1-induced nuclear translocation of telomerase reverse transcriptase protein", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:3fE2CSJIrl8C", "citedby": "241"}, {"bib": {"title": "The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions", "year": "2006"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:YOwf2qJgpHMC", "citedby": "240"}, {"bib": {"title": "Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of \u03b21-integrin and phosphatidylinositol 3\u2032-kinase/AKT signaling", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:hqOjcs7Dif8C", "citedby": "231"}, {"bib": {"title": "JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Se3iqnhoufwC", "citedby": "229"}, {"bib": {"title": "Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:5nxA0vEk-isC", "citedby": "207"}, {"bib": {"title": "Cytokines modulate telomerase activity in a human multiple myeloma cell line", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:8k81kl-MbHgC", "citedby": "207"}, {"bib": {"title": "Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood\u2013retinal barrier breakdown in a model of streptozotocin-induced diabetes", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:M3ejUd6NZC8C", "citedby": "204"}, {"bib": {"title": "Molecular pathology of thyroid cancer: diagnostic and clinical implications", "year": "2008"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:JV2RwH3_ST0C", "citedby": "198"}, {"bib": {"title": "Focus on multiple myeloma", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ULOm3_A8WrAC", "citedby": "190"}, {"bib": {"title": "Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:dhFuZR0502QC", "citedby": "188"}, {"bib": {"title": "Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:_kc_bZDykSQC", "citedby": "185"}, {"bib": {"title": "Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors", "year": "2012"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:XiVPGOgt02cC", "citedby": "169"}, {"bib": {"title": "Essential role of caveolae in interleukin-6-and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:kNdYIx-mwKoC", "citedby": "169"}, {"bib": {"title": "Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:4TOpqqG69KYC", "citedby": "168"}, {"bib": {"title": "A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:4JMBOYKVnBMC", "citedby": "166"}, {"bib": {"title": "Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM)", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:L8Ckcad2t8MC", "citedby": "165"}, {"bib": {"title": "Intracellular regulation of tumor necrosis factor\u2013related apoptosis-inducing ligand\u2013induced apoptosis in human multiple myeloma cells", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:MXK_kJrjxJIC", "citedby": "165"}, {"bib": {"title": "Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:QIV2ME_5wuYC", "citedby": "163"}, {"bib": {"title": "Ewing\u2019s sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:qxL8FJ1GzNcC", "citedby": "161"}, {"bib": {"title": "Identification of genes modulated in multiple myeloma using genetically identical twin samples", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:mVmsd5A6BfQC", "citedby": "160"}, {"bib": {"title": "CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Zph67rFs4hoC", "citedby": "160"}, {"bib": {"title": "Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover", "year": "2013"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:dTyEYWd-f8wC", "citedby": "158"}, {"bib": {"title": "Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235", "year": "2009"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:lvd772isFD0C", "citedby": "143"}, {"bib": {"title": "Antitumor Effects of the Proteasome Inhibitor Bortezomib in Medullary and Anaplastic Thyroid Carcinoma Cells in Vitro", "year": "2006"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:mB3voiENLucC", "citedby": "142"}, {"bib": {"title": "Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto\u2019s thyroiditis", "year": "1998"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:aqlVkmm33-oC", "citedby": "141"}, {"bib": {"title": "Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:4DMP91E08xMC", "citedby": "140"}, {"bib": {"title": "Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report", "year": "1997"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:R3hNpaxXUhUC", "citedby": "138"}, {"bib": {"title": "An epigenomic approach to therapy for tamoxifen-resistant breast cancer", "year": "2014"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:S16KYo8Pm5AC", "citedby": "135"}, {"bib": {"title": "Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:7PzlFSSx8tAC", "citedby": "130"}, {"bib": {"title": "CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3\u2013kinase/AKT/NF-\u03baB signaling", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:hC7cP41nSMkC", "citedby": "127"}, {"bib": {"title": "Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implications", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:hFOr9nPyWt4C", "citedby": "122"}, {"bib": {"title": "Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case\u2013control study", "year": "2009"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ldfaerwXgEUC", "citedby": "117"}, {"bib": {"title": "Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation", "year": "1998"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ZeXyd9-uunAC", "citedby": "114"}, {"bib": {"title": "Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase", "year": "1998"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:9ZlFYXVOiuMC", "citedby": "109"}, {"bib": {"title": "Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors", "year": "2008"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:M3NEmzRMIkIC", "citedby": "107"}, {"bib": {"title": "Novel histone deacetylase inhibitors in the treatment of thyroid cancer", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:r0BpntZqJG4C", "citedby": "104"}, {"bib": {"title": "VEGF-dependent conjunctivalization of the corneal surface", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:HDshCWvjkbEC", "citedby": "103"}, {"bib": {"title": "Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:IWHjjKOFINEC", "citedby": "102"}, {"bib": {"title": "Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:maZDTaKrznsC", "citedby": "95"}, {"bib": {"title": "Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:-f6ydRqryjwC", "citedby": "94"}, {"bib": {"title": "The role of Fas and FasL as mediators of anticancer chemotherapy", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:TQgYirikUcIC", "citedby": "93"}, {"bib": {"title": "Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:O3NaXMp0MMsC", "citedby": "92"}, {"bib": {"title": "Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:qUcmZB5y_30C", "citedby": "91"}, {"bib": {"title": "Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:lSLTfruPkqcC", "citedby": "88"}, {"bib": {"title": "Aplidin, a marine organism\u2013derived compound with potent antimyeloma activity in vitro and in vivo", "year": "2008"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:J_g5lzvAfSwC", "citedby": "86"}, {"bib": {"title": "Antitumor activity of lysophosphatidic acid acyltransferase-\u03b2 inhibitors, a novel class of agents, in multiple myeloma", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:_Qo2XoVZTnwC", "citedby": "86"}, {"bib": {"title": "Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion", "year": "1999"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:e5wmG9Sq2KIC", "citedby": "85"}, {"bib": {"title": "A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer", "year": "2013"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:kuK5TVdYjLIC", "citedby": "84"}, {"bib": {"title": "Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer", "year": "2014"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:HbR8gkJAVGIC", "citedby": "81"}, {"bib": {"title": "GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex", "year": "2014"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:foquWX3nUaYC", "citedby": "77"}, {"bib": {"title": "Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:j3f4tGmQtD8C", "citedby": "76"}, {"bib": {"title": "Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib", "year": "2009"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:g5m5HwL7SMYC", "citedby": "73"}, {"bib": {"title": "Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis", "year": "2006"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:isC4tDSrTZIC", "citedby": "72"}, {"bib": {"title": "Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation", "year": "2006"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:blknAaTinKkC", "citedby": "71"}, {"bib": {"title": "The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer.", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:BqipwSGYUEgC", "citedby": "71"}, {"bib": {"title": "Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:iH-uZ7U-co4C", "citedby": "69"}, {"bib": {"title": "Targeting BRAFV600E in thyroid carcinoma: therapeutic implications", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:YFjsv_pBGBYC", "citedby": "68"}, {"bib": {"title": "Circulating Adiponectin Is Inversely Associated with Risk of Thyroid Cancer: In Vivo and in Vitro Studies", "year": "2011"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:b0M2c_1WBrUC", "citedby": "61"}, {"bib": {"title": "Superoxide-dependent and-independent mitochondrial signaling during apoptosis in multiple myeloma cells", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:TFP_iSt0sucC", "citedby": "60"}, {"bib": {"title": "Coactivator SRC-2\u2013dependent metabolic reprogramming mediates prostate cancer survival and metastasis", "year": "2015"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ruyezt5ZtCIC", "citedby": "58"}, {"bib": {"title": "Constitutive nuclear factor-\u03baB activity is crucial for human retinoblastoma cell viability", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:bEWYMUwI8FkC", "citedby": "58"}, {"bib": {"title": "Thymoma-associated multiorgan autoimmunity: A graft-versus-host\u2013like disease", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:SeFeTyx0c_EC", "citedby": "57"}, {"bib": {"title": "Skin manifestations of Cushing disease in children and adolescents before and after the resolution of hypercortisolemia", "year": "1998"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:35N4QoGY0k4C", "citedby": "54"}, {"bib": {"title": "Proteasome inhibition as a new therapeutic principle in hematological malignancies", "year": "2006"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:GnPB-g6toBAC", "citedby": "53"}, {"bib": {"title": "Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:2P1L_qKh6hAC", "citedby": "53"}, {"bib": {"title": "Novel biologically based therapies for Waldenstrom's macroglobulinemia", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:k_IJM867U9cC", "citedby": "53"}, {"bib": {"title": "Fas-mediated apoptosis in Ewing's sarcoma cell lines by metalloproteinase inhibitors", "year": "1999"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:NMxIlDl6LWMC", "citedby": "53"}, {"bib": {"title": "B-Raf inhibition in the clinic: present and future", "year": "2016"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:9pM33mqn1YgC", "citedby": "52"}, {"bib": {"title": "Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer", "year": "2014"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:kz9GbA2Ns4gC", "citedby": "50"}, {"bib": {"title": "CC-5013 (Celgene).", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:fFSKOagxvKUC", "citedby": "50"}, {"bib": {"title": "Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:vV6vV6tmYwMC", "citedby": "48"}, {"bib": {"title": "The Gem GTP-binding protein promotes morphological differentiation in neuroblastoma", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:NaGl4SEjCO4C", "citedby": "47"}, {"bib": {"title": "Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer", "year": "2016"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:HtEfBTGE9r8C", "citedby": "46"}, {"bib": {"title": "Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy", "year": "2011"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:pyW8ca7W8N0C", "citedby": "46"}, {"bib": {"title": "Role of \u03b14 integrin (CD49d) in the pathogenesis of diabetic retinopathy", "year": "2009"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:rO6llkc54NcC", "citedby": "46"}, {"bib": {"title": "Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas", "year": "2009"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:fPk4N6BV_jEC", "citedby": "46"}, {"bib": {"title": "The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:3s1wT3WcHBgC", "citedby": "45"}, {"bib": {"title": "2-Methoxyestardiol and bortezomib/proteasome-inhibitor overcome dexamethasone-resistance in multiple myeloma cells by modulating Heat Shock Protein-27", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:nZcligLrVowC", "citedby": "41"}, {"bib": {"title": "NF-KB as a Therapeutic Target in Multiple Myeloma (MM)", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:_axFR9aDTf0C", "citedby": "41"}, {"bib": {"title": "Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:RYcK_YlVTxYC", "citedby": "39"}, {"bib": {"title": "Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: Therapeutic applications and considerations", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:RGFaLdJalmkC", "citedby": "39"}, {"bib": {"title": "Proteasome inhibitors as therapeutics", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ns9cj8rnVeAC", "citedby": "38"}, {"bib": {"title": "Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:hMod-77fHWUC", "citedby": "38"}, {"bib": {"title": "\u03b2-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:70eg2SAEIzsC", "citedby": "37"}, {"bib": {"title": "Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer", "year": "2016"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:DUooU5lO8OsC", "citedby": "35"}, {"bib": {"title": "Moving beyond the androgen receptor (AR): targeting AR-interacting proteins to treat prostate cancer", "year": "2016"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:a9-T7VOCCH8C", "citedby": "35"}, {"bib": {"title": "Methods and compositions for treating cancer using proteasome inhibitors", "year": "2011"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:0CzhzZyukY4C", "citedby": "31"}, {"bib": {"title": "The IGF/IGF-1R system is a major therapeutic target for multiple myeloma, other hematologic malignancies and solid tumors.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:t7zJ5fGR-2UC", "citedby": "30"}, {"bib": {"title": "Thalidomide (THAL) and Immunomodulatory Derivatives (IMiDS) Augment Natural Killer (NK) Cell Cytotocixity in Multiple Myeloma (MM)"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:kVjdVfd2voEC", "citedby": "30"}, {"bib": {"title": "SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein", "year": "2017"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:4vMrXwiscB8C", "citedby": "29"}, {"bib": {"title": "Cognitive effects of hormonal therapy in older adults", "year": "2008"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:a0OBvERweLwC", "citedby": "29"}, {"bib": {"title": "Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:u_35RYKgDlwC", "citedby": "27"}, {"bib": {"title": "Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:M05iB0D1s5AC", "citedby": "27"}, {"bib": {"title": "In vitro anti\u2010myeloma activity of the Aurora kinase inhibitor VE\u2010465", "year": "2009"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ZHo1McVdvXMC", "citedby": "26"}, {"bib": {"title": "In situ detection of microRNAs146b, 221 and 222 in human carcinoma tissues reveals tumor-type specific expression patterns.", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ClCfbGk0d_YC", "citedby": "26"}, {"bib": {"title": "Circulating thyroglobulin transcytosed by thyroid cells is complexed with secretory components of its endocytic receptor megalin", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:4OULZ7Gr8RgC", "citedby": "24"}, {"bib": {"title": "Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation", "year": "2017"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:IUKN3-7HHlwC", "citedby": "23"}, {"bib": {"title": "Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer", "year": "2019"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Bg7qf7VwUHIC", "citedby": "22"}, {"bib": {"title": "Fas/Fas ligand-associated apoptosis in experimental autoimmune uveoretinitis in rodents: role of proinflammatory corticotropin-releasing hormone", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:HoB7MX3m0LUC", "citedby": "20"}, {"bib": {"title": "Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasias", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:pqnbT2bcN3wC", "citedby": "19"}, {"bib": {"title": "Abiraterone acetate, a first-in-class CYP17 inhibitor, establishes a new treatment paradigm in castration-resistant prostate cancer", "year": "2012"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:UxriW0iASnsC", "citedby": "18"}, {"bib": {"title": "miR-137 targets p160 steroid receptor coactivators SRC1, SRC2, and SRC3 and inhibits cell proliferation", "year": "2015"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:bz8QjSJIRt4C", "citedby": "17"}, {"bib": {"title": "HER2 signaling drives DNA anabolism and proliferation through SRC-3 phosphorylation and E2F1-regulated genes", "year": "2016"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:sNmaIFBj_lkC", "citedby": "16"}, {"bib": {"title": "The mTOR Inhibitor RAD001 (everolimus) Is Active Against Multiple Myeloma Cells In Vitro and in Vivo.", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:zA6iFVUQeVQC", "citedby": "15"}, {"bib": {"title": "Recurring oral giant cell lesion in a child with X-linked hypophosphatemic rickets: Clinical manifestation of occult parathyroidism?", "year": "1995"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:D03iK_w7-QYC", "citedby": "15"}, {"bib": {"title": "Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: patient considerations, novel opportunities, and future directions", "year": "2013"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Y5dfb0dijaUC", "citedby": "14"}, {"bib": {"title": "Proteasome inhibition as a therapeutic strategy for hematologic malignancies", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:yD5IFk8b50cC", "citedby": "13"}, {"bib": {"title": "The proteasome inhibitor bortezomib (PS-341) is active against Waldenstrom's macroglobulinemia (WM).", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:vDijr-p_gm4C", "citedby": "13"}, {"bib": {"title": "The HSP90 molecular chaperone as a novel therapeutic target in hematologic malignancies.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:uWiczbcajpAC", "citedby": "13"}, {"bib": {"title": "Protein kinase C inhibitors sensitize GNAQ mutant uveal melanoma cells to ionizing radiation", "year": "2014"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:WZBGuue-350C", "citedby": "12"}, {"bib": {"title": "Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications", "year": "2009"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:EUQCXRtRnyEC", "citedby": "12"}, {"bib": {"title": "LAQ824 is a novel histone deacetylase inhibitor with significant activity against multiple myeloma: Results of a pre-clinical evaluation in vitro and in vivo.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:r_AWSJRzSzQC", "citedby": "12"}, {"bib": {"title": "The essential role of GATA transcription factors in adult murine prostate", "year": "2016"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:2VqYfGB8ITEC", "citedby": "11"}, {"bib": {"title": "AT cell-binding fragment of fibrinogen can prevent autoimmunity", "year": "2010"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:NhqRSupF_l8C", "citedby": "10"}, {"bib": {"title": "Aplidine for multiple myeloma treatment", "year": "2008"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:u9iWguZQMMsC", "citedby": "10"}, {"bib": {"title": "Activity of New Heat Shock Protein 90 (hsp90) Inhibitor NVP-AUY922 Against Myeloma Cells Sensitive and Resistant to Conventional Agents.", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ipzZ9siozwsC", "citedby": "10"}, {"bib": {"title": "Phase I Clinical Trial of Oral Administration of the Histone Deacetylase (HDAC) Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Relapsed/Refractory Multiple \u2026", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:dfsIfKJdRG4C", "citedby": "10"}, {"bib": {"title": "Hsp90 inhibitors prolong survival in a SCID/NOD mice model of diffuse multiple myeloma: therapeutic implications", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:86PQX7AUzd4C", "citedby": "10"}, {"bib": {"title": "Extended rituximab therapy is highly effective and facilitates hematological recovery in patients with lymphoplasmacytic lymphoma (Waldenstrom\u2019s macroglobulinemia, WM)", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:9Nmd_mFXekcC", "citedby": "10"}, {"bib": {"title": "Dasatinib (BMS-354825): A Multi-Targeted Kinase Inhibitor with Activity Against Multiple Myeloma.", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:f2IySw72cVMC", "citedby": "9"}, {"bib": {"title": "IPI-504: A Novel hsp90 Inhibitor with In Vitro and In Vivo Anti-Tumor Activity.", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:bFI3QPDXJZMC", "citedby": "9"}, {"bib": {"title": "Effect of imatinib mesylate (Gleevec) on anaplastic thyroid carcinoma cell lines", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:_xSYboBqXhAC", "citedby": "9"}, {"bib": {"title": "The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces growth arrest and apoptosis in multiple myeloma (MM) and Waldenstrom's macroglobulinemia (WM \u2026", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:hMsQuOkrut0C", "citedby": "8"}, {"bib": {"title": "Anti-Tumor Activity of KOS-953, a Cremophor-Based Formulation of the hsp90 Inhibitor 17-AAG.", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:cFHS6HbyZ2cC", "citedby": "7"}, {"bib": {"title": "Apoptotic signaling induced by immunomodulatory thalidomide analogs (IMiDs) in human multiple myeloma cells: Therapeutic implications.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:5awf1xo2G04C", "citedby": "7"}, {"bib": {"title": "Abiraterone acetate for metastatic prostate cancer in patients with suboptimal biochemical response to hormone induction", "year": "2017"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:dBIO0h50nwkC", "citedby": "6"}, {"bib": {"title": "Increased expression of androgen receptor (AR) and enzymes involved in androgen synthesis in metastatic prostate cancer: Targets for novel personalized therapies", "year": "2009"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:nb7KW1ujOQ8C", "citedby": "6"}, {"bib": {"title": "Defibrotide (DF) has anti-neoplastic activity against multiple myeloma: Clinical implications for the incorporation of DF in cytotoxic chemotherapeutic regimens.", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:KbBQZpvPDL4C", "citedby": "6"}, {"bib": {"title": "The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: Therapeutic applications.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:LdasjJ6CEcoC", "citedby": "6"}, {"bib": {"title": "ICG-001 exerts potent anticancer activity against uveal melanoma cells", "year": "2018"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Aul-kAQHnToC", "citedby": "5"}, {"bib": {"title": "Molecular genetics of thyroid cancer: pathogenetic significance and clinical applications", "year": "2010"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:IRz6iEL74y4C", "citedby": "5"}, {"bib": {"title": "Avicins: a novel class of anti-myeloma agents.", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:abG-DnoFyZgC", "citedby": "5"}, {"bib": {"title": "HMG-CoA inhibitors (statins) induce growth arrest, apoptosis of multiple myeloma (MM) and Waldenstrom's macroglobulinemia (WM) cells and enhance their sensitivity to \u2026", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:AvfA0Oy_GE0C", "citedby": "5"}, {"bib": {"title": "IGF-1-Induced activation of NF-kappa B and upregulation of intracellular anti-apoptotic proteins in human multiple myeloma cells: Therapeutic implications.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:EYYDruWGBe4C", "citedby": "5"}, {"bib": {"title": "Immunomodulatory derivatives (IMiDs) of thalidomide (Thal) inhibit the proliferation of multiple myeloma (MM) cell lines and block VEGF-induced activation of the MAPK-pathway.", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:yB1At4FlUx8C", "citedby": "5"}, {"bib": {"title": "HSP90 MOLECULAR CHAPERONE: A NOVEL THERAPEUTIC TARGET FOR B-CELL LYMPHOMAS AND MULTIPLE MYELOMA."}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:DJbcl8HfkQkC", "citedby": "5"}, {"bib": {"title": "Cell Co-Culture Systems and Uses Thereof", "year": "2010"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:l7t_Zn2s7bgC", "citedby": "4"}, {"bib": {"title": "Methods for inhibiting tumor cell growth", "year": "2010"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:5qfkUJPXOUwC", "citedby": "4"}, {"bib": {"title": "Compartment-specific bioluminescence imaging (CS-BLI): A high-throughput approach to identify novel anti-myeloma therapies that overcome the protection of stromal cells", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:4MWp96NkSFoC", "citedby": "4"}, {"bib": {"title": "Induction of apoptosis by lysophosphatidic acid acyltransferase (LPAAT)-beta inhibitors in multiple myeloma (MM).", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:yqoGN6RLRZoC", "citedby": "4"}, {"bib": {"title": "High throughput global proteomic analysis of the signaling state of human multiple myeloma cells.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:VLnqNzywnoUC", "citedby": "4"}, {"bib": {"title": "Receptor activator of nuclear factor-kappa B (RANK) ligand expression: In human multiple myeloma cells.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:vbGhcppDl1QC", "citedby": "4"}, {"bib": {"title": "Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in B-cell malignancies.", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ye4kPcJQO24C", "citedby": "4"}, {"bib": {"title": "Harnessing androgen receptor pathway activation for targeted alpha particle Radioimmunotherapy of breast Cancer", "year": "2019"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:BJbdYPG6LGMC", "citedby": "3"}, {"bib": {"title": "Anti-Myeloma Activity of Selective PI-3K/PDK/mTOR Inhibitor BEZ235.", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ILKRHgRFtOwC", "citedby": "3"}, {"bib": {"title": "Anti-Myeloma Activity of the Small-Molecule Aurora Kinase Inhibitor VE465.", "year": "2006"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:L7CI7m0gUJcC", "citedby": "3"}, {"bib": {"title": "Insulin-like growth factor-1 receptor (IGF-1R/CD221): A target for monoclonal antibody-based therapy to overcome drug-resistance in multiple myeloma (MM), other hematologic \u2026", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:KxtntwgDAa4C", "citedby": "3"}, {"bib": {"title": "In vitro and in vivo molecular profiling of multiple myeloma (MM) cell interactions with bone marrow (BM) microenvironment: Insight into the role of novel anti-MM agents in \u2026", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:g3aElNc5_aQC", "citedby": "3"}, {"bib": {"title": "P2X7 polymorphism and chronic lymphocytic leukaemia", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:9c2xU6iGI7YC", "citedby": "3"}, {"bib": {"title": "Gene expression and proteomic profiling of multiple myeloma (MM) cells co-cultured with bone marrow (BM) stromal cells or stimulated with BM-derived cytokines: Implications for \u2026", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:EkHepimYqZsC", "citedby": "3"}, {"bib": {"title": "Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is modulated by FLICE-inhibitory protein (FLIP) and procaspase-8 in multiple myeloma cells-Response", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:uDGL6kOW6j0C", "citedby": "3"}, {"bib": {"title": "beta-Lapachone demonstrates activity against drug resistant multiple myeloma (MM) cell lines and patient cells.", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:z_wVstp3MssC", "citedby": "3"}, {"bib": {"title": "Phase II trial of abiraterone acetate (AA) treatment for metastatic prostate cancer (PC) patients with a PSA of more than four following initial androgen deprivation therapy \u2026", "year": "2015"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:NXb4pA-qfm4C", "citedby": "2"}, {"bib": {"title": "Use of reversine and analogs for treatment of cancer", "year": "2013"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:D_sINldO8mEC", "citedby": "2"}, {"bib": {"title": "Grif fi n JD, Richardson PG, Anderson KC, Mitsiades CS. Tumor cell-speci fic bioluminescence platform to identify stroma-induced changes to anticancer drug activity", "year": "2010"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:HIFyuExEbWQC", "citedby": "2"}, {"bib": {"title": "Activity of CDK1/2 Inhibitor LCQ195 Against Multiple Myeloma Cells.", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:URolC5Kub84C", "citedby": "2"}, {"bib": {"title": "Mechanistic insight into anti-tumor effects of reversine in human myeloma and lymphoma cell lines", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:0KyAp5RtaNEC", "citedby": "2"}, {"bib": {"title": "PKC412 Is a Multi-Targeting Kinase Inhibitor with Activity Against Multiple Myeloma In Vitro and In Vivo.", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:CHSYGLWDkRkC", "citedby": "2"}, {"bib": {"title": "Blockade of IL-6 triggered signaling cascades by PS-341 (Velcade (R)) via caspase-dependent downregulation of gp130 in multiple myeloma (MM)", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:F9fV5C73w3QC", "citedby": "2"}, {"bib": {"title": "Immunomodulatory thalidomide derivatives have activity against tumor cells from Waldenstrom's macroglobulinemia.", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:uc_IGeMz5qoC", "citedby": "2"}, {"bib": {"title": "Molecular mechanisms mediating anti-myeloma activity of proteasome inhibitor PS-341.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:BzfGm06jWhQC", "citedby": "2"}, {"bib": {"title": "Histone deacetylase (HDAC) inhibitors in the treatment of multiple myeloma (MM): Mechanisms of action and therapeutic applications.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:nrtMV_XWKgEC", "citedby": "2"}, {"bib": {"title": "Heat shock protein-27 confers drug-resistance in multiple myeloma cells.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Ehil0879vHcC", "citedby": "2"}, {"bib": {"title": "NF-kappa B and p38 kinase as novel therapeutic targets for human multiple myeloma.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ML0RJ9NH7IQC", "citedby": "2"}, {"bib": {"title": "Thiazolidinediones: A novel class of agents with anti-myeloma activity.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Fu2w8maKXqMC", "citedby": "2"}, {"bib": {"title": "The role of vascular endothelial growth factor (VEGF) in the pathophysiology of multiple myeloma (MM).", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:p__nRnzSRKYC", "citedby": "2"}, {"bib": {"title": "Multimodal action of ONECUT2 in driving neuroendocrine prostate cancer", "year": "2019"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:wMgC3FpKEyYC", "citedby": "1"}, {"bib": {"title": "Prostate cancer screening", "year": "2017"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:2tRrZ1ZAMYUC", "citedby": "1"}, {"bib": {"title": "Survival outcome of veterans with myelodysplastic syndrome (MDS) treated with statins.", "year": "2012"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:umqufdRvDiIC", "citedby": "1"}, {"bib": {"title": "The protein kinase C (PKC)/protein kinase D (PKD)/steroid receptor coactivator (SRC)-3 pathway is an important therapeutic target in G\u03b1-mutant uveal melanomas", "year": "2012"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:GtLg2Ama23sC", "citedby": "1"}, {"bib": {"title": "Treatment of Multiple Myeloma", "year": "2010"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:vRqMK49ujn8C", "citedby": "1"}, {"bib": {"title": "The antidiabetic biguanide metformin induces growth arrest in multiple myeloma cells in vitro, overcoming the effect of stromal cells", "year": "2008"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:WqliGbK-hY8C", "citedby": "1"}, {"bib": {"title": "Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95-2 (vol 14, pg 713, 2007)", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:NJ774b8OgUMC", "citedby": "1"}, {"bib": {"title": "Antimyeloma efficacy of plitidepsin (aplidin (R)): from bench to the bedside", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:XvxMoLDsR5gC", "citedby": "1"}, {"bib": {"title": "Anti-Myeloma Activity of the Dual Akt/p70S6K Inhibitor EXEL-6075.", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Z5m8FVwuT1cC", "citedby": "1"}, {"bib": {"title": "Antimyeloma Efficacy of Plitidepsin (Aplidin\u00ae): From Bench to the Bedside.", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:P5F9QuxV20EC", "citedby": "1"}, {"bib": {"title": "Requirement of Caspase-8 Versus Caspase-9 during Apoptosis in Multiple Myeloma Cells Induced by Bortezomib- or a Novel Proteasome Inhibitor NPI-0052.", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:dshw04ExmUIC", "citedby": "1"}, {"bib": {"title": "Novel Histone Deacetylase Inhibitors in theTreatment of Thyroid Cancer", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:mNrWkgRL2YcC", "citedby": "1"}, {"bib": {"title": "NVP-AEW541: A Selective Small Molecule IGF-1R Tyrosine Kinase Inhibitor Is Active Against Multiple Myeloma and Other Hematologic Neoplasias and Solid Tumors.", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Tiz5es2fbqcC", "citedby": "1"}, {"bib": {"title": "Intensive insulin therapy\u2013induced vascular leakage and leukostasis in diabetes are decreased by anti\u2013IGF", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:OU6Ihb5iCvQC", "citedby": "1"}, {"bib": {"title": "Characterization of selective small molecule kinase inhibitors of IGF-IR and their in vitro and in vivo activity against multiple myeloma, other hematologic malignancies and \u2026", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:rmuvC79q63oC", "citedby": "1"}, {"bib": {"title": "Pre-clinical studies in support of the clinical development of Aplidin (R)(APL) for the treatment of Multiple Myeloma (MM).", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:PR6Y55bgFSsC", "citedby": "1"}, {"bib": {"title": "Molecular profiles of sensitivity or resistance of multiple myeloma (MM) cells to conventional and novel anti-myeloma agents: Clinical implications for rationale design of \u2026", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:PVjk1bu6vJQC", "citedby": "1"}, {"bib": {"title": "Heat shock protein 90 (hsp90) inhibitors: A novel class of agents with activity against Waldenstrom's macroglobulinemia (WM): Pre-clinical studies, and molecular profiling and \u2026", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:eq2jaN3J8jMC", "citedby": "1"}, {"bib": {"title": "Gene expression analysis of tumor cells sensitive and resistant to PS-341 (Bortezomib) treatment: Clinical implications.", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:fEOibwPWpKIC", "citedby": "1"}, {"bib": {"title": "CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3\u2013kinase/AKT/NF-B signaling", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:8xutWZnSdmoC", "citedby": "1"}, {"bib": {"title": "Gene expression and proteomic profiling of drug-treated multiple myeloma (MM) cells: mechanisms of drug-responsiveness vs. resistance and rationale for design of novel \u2026", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:BUYA1_V_uYcC", "citedby": "1"}, {"bib": {"title": "IGF-1 induced telomerase activity and protects against apoptosis in multiple myeloma cells.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:a3BOlSfXSfwC", "citedby": "1"}, {"bib": {"title": "Expression and regulation of soluble TRAIL (sTRAIL) in multiple myeloma (MM) and Waldenstrom's macroglobulinemia (WM).", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:2KloaMYe4IUC", "citedby": "1"}, {"bib": {"title": "Intracellular regulation of tumor necrosis factor (TNF)-Related Apoptosis Inducing Ligand (TRAIL/Apo2L)-induced apoptosis in human multiple myeloma cells.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:7T2F9Uy0os0C", "citedby": "1"}, {"bib": {"title": "beta-lapachone, a novel topoisomerase I inhibitor, has significant cytotoxicity against multiple myeloma (MM) cell lines and patient cells.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ZzlSgRqYykMC", "citedby": "1"}, {"bib": {"title": "Thalidomide (Thal) and immunomodulatory derivatives (IMiDS) augment natural killer (NK) cell cytotoxicty in multiple myeloma (MM).", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:zLWjf1WUPmwC", "citedby": "1"}, {"bib": {"title": "Chronic effects of a nonpeptide CRH type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation", "year": "1998"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:jL-93Qbq4QoC", "citedby": "1"}, {"bib": {"title": "Discovery, Structure\u2013Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP", "year": "2020"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:7BrZ7Jt4UNcC", "citedby": "0"}, {"bib": {"title": "Glucocorticoids mediate adverse events of deep androgen receptor axis inhibition in prostate cancer patients", "year": "2020"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:MpfHP-DdYjUC", "citedby": "0"}, {"bib": {"title": "K-11706 exerts potent anti-cancer activity via suppression of GATA2/AR/cMyc signaling axis in castration resistant prostate cancer", "year": "2019"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:PaBasH6fAo0C", "citedby": "0"}, {"bib": {"title": "Abstract B128: K-11706 exerts potent anti-cancer activity via suppression of GATA2/AR/cMyc signaling axis in castration resistant prostate cancer", "year": "2019"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ubry08Y2EpUC", "citedby": "0"}, {"bib": {"title": "Correction: Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer (Cancer Research (2014) 74 (5631-5643", "year": "2019"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:48xauSegjOkC", "citedby": "0"}, {"bib": {"title": "Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover (vol 110, pg 6997, 2013)", "year": "2019"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:CaZNVDsoPx4C", "citedby": "0"}, {"bib": {"title": "A novel therapeutic target in lethal prostate cancer in African American males", "year": "2019"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:otzGkya1bYkC", "citedby": "0"}, {"bib": {"title": "Diagnostic/prognostic marker and therapeutic target for cancer", "year": "2019"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:OTTXONDVkokC", "citedby": "0"}, {"bib": {"title": "Cell co-culture systems and uses thereof", "year": "2019"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Ak0FvsSvgGUC", "citedby": "0"}, {"bib": {"title": "SRC-2 use as metabolic biomarker for diagnosis and treatment of metastatic prostate cancer", "year": "2018"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:QYdC8u9Cj1oC", "citedby": "0"}, {"bib": {"title": "A highly potent novel class of P160-SRC inhibitors for the treatment of castration-resistant prostate cancer.", "year": "2018"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:artPoR2Yc-kC", "citedby": "0"}, {"bib": {"title": "A highly potent novel class of SRC-3 inhibitors for the treatment of uveal melanoma", "year": "2018"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:gKiMpY-AVTkC", "citedby": "0"}, {"bib": {"title": "A novel mechanism to drive castration-resistant prostate cancer", "year": "2018"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:5MTHONV0fEkC", "citedby": "0"}, {"bib": {"title": "A novel approach for targeting androgen receptor signaling axis in prostate cancer", "year": "2017"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:OcBU2YAGkTUC", "citedby": "0"}, {"bib": {"title": "Advanced Stage Prostate Cancer: Controversies in Management", "year": "2017"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:fbc8zXXH2BUC", "citedby": "0"}, {"bib": {"title": "Advanced Prostate Cancer Survivorship Challenges and Issues", "year": "2017"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:u-coK7KVo8oC", "citedby": "0"}, {"bib": {"title": "Inhibition of hexose monophosphate pathway promotes castration resistant prostate cancer", "year": "2016"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:WJVC3Jt7v1AC", "citedby": "0"}, {"bib": {"title": "Bromodomain (BRD) inhibition as a novel strategy to inhibit the Microphthalmia-associated transcription factor (MITF) axis in uveal melanoma (UM)", "year": "2015"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:4fGpz3EwCPoC", "citedby": "0"}, {"bib": {"title": "Sensitivity and Resistance of Uveal Melanoma (UM) cells to PKC inhibition: Role of the Steroid Receptor Coactivator (SRC)-3", "year": "2014"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Ri6SYOTghG4C", "citedby": "0"}, {"bib": {"title": "Cell Co-Culture Systems and Uses Thereof", "year": "2013"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:VaXvl8Fpj5cC", "citedby": "0"}, {"bib": {"title": "Protein Kinase C Inhibitors as Novel Radiosensitizing Agents in the Treatment of Primary GNAQ Mutant Uveal Melanoma", "year": "2013"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:LI9QrySNdTsC", "citedby": "0"}, {"bib": {"title": "Microphthalmia-associated transcription factor (MITF) and Steroid Receptor Coactivator (SRC)-3 cooperate to promote proliferation, survival and metabolism in G\u03b1-mutant uveal \u2026", "year": "2013"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:kh2fBNsKQNwC", "citedby": "0"}, {"bib": {"title": "Abstract P6-10-03: The PKC inhibitor PKC412 antagonizes breast cancer cell growth and enhances tamoxifen sensitivity", "year": "2012"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:-FonjvnnhkoC", "citedby": "0"}, {"bib": {"title": "Genotype-Dependent Sensitivity Of Ocular Melanoma Cell Lines To Inhibitors Of Kinases, Including BRAF, MEK And Akt: Rationale For Personalized Therapy", "year": "2011"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:_FM0Bhl9EiAC", "citedby": "0"}, {"bib": {"title": "In Vitro and In Vivo Anticancer Effects of Metformin and the AMP-Activated Protein Kinase (AMPK) Activator 5-Aminoimidazole-4-Carboxamide-1-beta-D-Ribofuranoside (AICAR \u2026", "year": "2010"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:kzcrU_BdoSEC", "citedby": "0"}, {"bib": {"title": "A gene expression signature associated with sensitivity to the multikinase inhibitor dasatinib: Implications for development of a noninvasive biomarker for personalized therapy \u2026", "year": "2010"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:t6usbXjVLHcC", "citedby": "0"}, {"bib": {"title": "Microenvironment-Dependent Synthetic Lethality: Implications for Tumor Pathophysiology and Anti-Cancer Drug Discovery.", "year": "2009"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:hkOj_22Ku90C", "citedby": "0"}, {"bib": {"title": "The Antidiabetic Biguanide Metformin Induces Growth Arrest in Retinoblastoma Cells in vitro", "year": "2009"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:FAceZFleit8C", "citedby": "0"}, {"bib": {"title": "Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas", "year": "2009"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ALROH1vI_8AC", "citedby": "0"}, {"bib": {"title": "Interactions of the Mdm2/p53 and Proteasome Pathways: Implications for Combination Strategies to Enhance the Anti-Myeloma Activity of Bortezomib", "year": "2008"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:j8SEvjWlNXcC", "citedby": "0"}, {"bib": {"title": "Compartment-Specific Bioluminescence Imaging (CS-BLI) High-Throughput Assays Provide Comparative Insights into the Impact of Osteoclasts Vs. Stromal Cells on Activity of Anti \u2026", "year": "2008"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:SdhP9T11ey4C", "citedby": "0"}, {"bib": {"title": "Antitumor Effects of the Histone Deacetylase Inhibitor Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Human Retinoblastoma Cell Lines: Therapeutic Implications", "year": "2008"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:8d8msizDQcsC", "citedby": "0"}, {"bib": {"title": "3 INVITED RET inhibition: therapeutic implications in thyroid cancer", "year": "2008"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:J-pR_7NvFogC", "citedby": "0"}, {"bib": {"title": "In Vitro and In Vivo Anti-Myeloma Activity of PRLX, an Orally-Bioavailable Agent Against Cells with Constitutive Activation of Ras or Its Downstream Pathway.", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:XD-gHx7UXLsC", "citedby": "0"}, {"bib": {"title": "Compartment-Specific Bioluminescence Imaging (CS-BLI): A High-Throughput Approach To Identify Novel Anti-Neoplastic Therapies That Overcome the Protection of Stromal Cells.", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:B3FOqHPlNUQC", "citedby": "0"}, {"bib": {"title": "In vitro and in vivo anti-myeloma activity of PRLX, an orally-bioavailable agent against mutant Ras-transformed cells", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:uJ-U7cs_P_0C", "citedby": "0"}, {"bib": {"title": "Avicins: A novel class of anti-myeloma agents", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:9vf0nzSNQJEC", "citedby": "0"}, {"bib": {"title": "TIMP3 Inhibits Vascular Leakage and Leukostasis in an Animal Model of Streptozotocin-Induced Diabetes", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:LO7wyVUgiFcC", "citedby": "0"}, {"bib": {"title": "A better way to evaluate cutaneous blood flow and treatment efficacy in systemic sclerosis.", "year": "2007"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:epqYDVWIO7EC", "citedby": "0"}, {"bib": {"title": "Reversine: A Chemical Probe Providing Insight into Myeloma Biology and Potential Therapeutic Applications.", "year": "2006"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:_Ybze24A_UAC", "citedby": "0"}, {"bib": {"title": "The Proteasome Inhibitor Bortezomib (Velcade, PS\u2013341) Induces Apoptosis in Human Retinoblastoma Cells: Therapeutic Implications", "year": "2006"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:0izLItjtcgwC", "citedby": "0"}, {"bib": {"title": "Geldanamycin Treatment Reduces Choroidal Neovascularization In A Murine Model", "year": "2006"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:anf4URPfarAC", "citedby": "0"}, {"bib": {"title": "Antimyeloma activity of heat shock protein-90 inhibition", "year": "2006"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:sJsF-0ZLhtgC", "citedby": "0"}, {"bib": {"title": "Anti\u2013FasL Neutralizing Antibody Increases the Efficacy of PDT and Reduces the Apoptotic Damage in a Rat Laser Model", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:BrmTIyaxlBUC", "citedby": "0"}, {"bib": {"title": "1 MOLECULAR PREDICTORS OF CLINICAL RESPONSE TO THE PROTEASOME INHIBITOR BORTEZOMIB: CLINICAL IMPLICATIONS FOR INDIVIDUALIZED PATIENT-SPECIFIC ANTI-CANCER THERAPEUTIC ALGORITHMS", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:yMeIxYmEMEAC", "citedby": "0"}, {"bib": {"title": "Thyroid carcinoma cells and Fas-mediated apoptosis.", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:eflP2zaiRacC", "citedby": "0"}, {"bib": {"title": "CLINICAL RESEARCH 2005 ABSTRACTS", "year": "2005"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:OP4eGU-M3BUC", "citedby": "0"}, {"bib": {"title": "Evaluation of the Ras/B-Raf/SHP-2 Axis in B Cell Malignancies.", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:8AbLer7MMksC", "citedby": "0"}, {"bib": {"title": "Targeting Mitochondrial Factor Smac/DIABLO as Therapy for Multiple Myeloma (MM).", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:4fKUyHm3Qg0C", "citedby": "0"}, {"bib": {"title": "Geldanamycin treatment reduces the inflammatory changes in the LPS\u2013induced uveitis rat model", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:WA5NYHcadZ8C", "citedby": "0"}, {"bib": {"title": "Inhibition of Very Late Antigen\u20134 (VLA\u20134) Prevents Endotoxin\u2013Induced Uveitis", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:HE397vMXCloC", "citedby": "0"}, {"bib": {"title": "Aspirin and COX\u20132 inhibition reduce diabetic endothelial cell death via a Fas\u2013FasL dependent mechanism.", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:5Ul4iDaHHb8C", "citedby": "0"}, {"bib": {"title": "IGF-II is a major proliferative/anti-apoptotic cytokine and a therapeutic target in multiple myeloma, other hematologic neoplasias and solid tumors.", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:5ugPr518TE4C", "citedby": "0"}, {"bib": {"title": "Synergistic cytotoxicity of immunomodulatory drugs IMiDs and monoclonal antibody SGN-40 against human multiple myeloma.", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:fQNAKQ3IYiAC", "citedby": "0"}, {"bib": {"title": "Molecular profiles of sensitivity or resistance of multiple myeloma (MM) cells to conventional and novel anti-myeloma agents: Clinical implications for rational design of \u2026", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:p2g8aNsByqUC", "citedby": "0"}, {"bib": {"title": "Avicins: A Novel Class of Anti-Myeloma Agents.(Poster# 675-III)", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:v1_lew4L6wgC", "citedby": "0"}, {"bib": {"title": "Low-dose 5-aza-2\u2032-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients", "year": "2004"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:5icHVeHT4IsC", "citedby": "0"}, {"bib": {"title": "Molecular profiling studies in a chemo-sensitive multiple myeloma (MM) cell line model and its chemo-resistant sub-lines: Insight into the regulation of tumor cell \u2026", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:tKAzc9rXhukC", "citedby": "0"}, {"bib": {"title": "Molecular profile of the anti-myeloma activity of histone deacetylase (HDAC) inhibitors: biological and therapeutic implications", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:uLbwQdceFCQC", "citedby": "0"}, {"bib": {"title": "Anti-tumor activity of lysophosphatidic acid acyltransferase (LPAAT)-beta inhibitors in multiple myeloma (MM).", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:JQOojiI6XY0C", "citedby": "0"}, {"bib": {"title": "Pre-clinical studies in support of the use of histone deacetylase (HDAC) inhibitors for the treatment of Waldenstrom's macroglobulinemia.", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:dQ2og3OwTAUC", "citedby": "0"}, {"bib": {"title": "IGF-II (IGF-2) is a major proliferative/anti-apoptotic cytokine and a therapeutic target in MM, other hematologic neoplasias and solid tumors.", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:N5tVd3kTz84C", "citedby": "0"}, {"bib": {"title": "The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Induces Growth Arrest and Apoptosis in Human Retinoblastoma Cell Lines", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:geHnlv5EZngC", "citedby": "0"}, {"bib": {"title": "Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Waldenstrom's macroglobulinemia (WM) remains an \u2026", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:3htObqc8RwsC", "citedby": "0"}, {"bib": {"title": "NEOPLASIA-Brief report The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: Therapeutic applications", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:eJXPG6dFmWUC", "citedby": "0"}, {"bib": {"title": "MECHANISMS OF SIGNAL TRANSDUCTION-Essential Role of Caveolae in Interleukin-6-and Insulin-like Growth Factor I-triggered Akt-1-mediated Survival of Multiple Myeloma Cells.", "year": "2003"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:sSrBHYA8nusC", "citedby": "0"}, {"bib": {"title": "The Role of IGF-I in the Pathogenesis of Diabetic Retinopathy", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:Mojj43d5GZwC", "citedby": "0"}, {"bib": {"title": "Essential role of lipid rafts in IL-6-and IGF-I-triggered Akt-1/PKB mediated survival of multiple myeloma cells.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:_OXeSy2IsFwC", "citedby": "0"}, {"bib": {"title": "Nuclear factor kappa B (NF-kappa B) p65 mediates nuclear translocation of telomerase reverse transcriptase (hTERT) protein in human multiple myeloma cell line.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:LhH-TYMQEocC", "citedby": "0"}, {"bib": {"title": "Whole-body real-time fluorescence imaging of disseminated GFP plus lesions in a SCID/NOD model of multiple myeloma: Implications for evaluations of novel therapies.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:-_dYPAW6P2MC", "citedby": "0"}, {"bib": {"title": "Identification of dysregulated genes in myeloma using a genetically identical twin samples.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ZfRJV9d4-WMC", "citedby": "0"}, {"bib": {"title": "Delineation of the apoptotic cascade induced by the proteasome inhibitor PS-341 in human multiple myeloma cells using microarray profiling and functional analysis: Clinical \u2026", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:1yQoGdGgb4wC", "citedby": "0"}, {"bib": {"title": "The proteasome inhibitor PS-341 modulates VEGF secretion and activity in multiple myeloma.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:VL0QpB8kHFEC", "citedby": "0"}, {"bib": {"title": "Differential oxidative stress responses during 2-methoxyestradiol (2ME2) and dexamthasone (Dex)-induced apoptosis in multiple myeloma (MM) cells.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:P7Ujq4OLJYoC", "citedby": "0"}, {"bib": {"title": "CD20-directed serotherapy in multiple myeloma: biological considerations and therapeutic applications.", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:lgwcVrK6X84C", "citedby": "0"}, {"bib": {"title": "Dharminder Chauhan, Paul Richardson, Nikhil C. Munshi, and Kenneth C. Anderson2 Jerome Upper Multiple Myeloma Center, Department of Adult Oncology, Dana-Farber Cancer Institute \u2026", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:ODE9OILHJdcC", "citedby": "0"}, {"bib": {"title": "CORRESPONDENCE-Response: Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is modulated by FLICE-inhibitory protein (FLIP) and procaspase-8 in \u2026", "year": "2002"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:xtRiw3GOFMkC", "citedby": "0"}, {"bib": {"title": "Inhibition of NF-kB activity induces loss of mitochondrial transmembrane potential and caspase-independent apoptosis in retinoblastoma cells.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:35r97b3x0nAC", "citedby": "0"}, {"bib": {"title": "Regular Articles-Tumor Biology-Fas-mediated Apoptosis in Neuroblastoma Requires Mitochondrial Activation and Is Inhibited by FLICE Inhibitor Protein and bcl-2.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:olpn-zPbct0C", "citedby": "0"}, {"bib": {"title": "Regular Articles-Tumor Biology-Matrix Metalloproteinase-7-mediated Cleavage of Fas Ligand Protects Tumor Cells from Chemotherapeutic Drug Cytotoxicity.", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:V3AGJWp-ZtQC", "citedby": "0"}, {"bib": {"title": "Regular Articles-Tumor Biology-Ewing's Sarcoma Family Tumors Are Sensitive to Tumor Necrosis Factor-related Apoptosis-inducing Ligand and Express Death Receptor 4 and Death \u2026", "year": "2001"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:q3oQSFYPqjQC", "citedby": "0"}, {"bib": {"title": "Ku86v translocates into cell membrane and associates with Ku70 in human multiple myeloma (MM) cells.", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:HeT0ZceujKMC", "citedby": "0"}, {"bib": {"title": "TRAIL induces apoptosis of chemotherapy sensitive and resistant myeloma cell lines and inhibits growth of human plasmacytomas xenografted in NU/XID/BG mice.", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:UHK10RUVsp4C", "citedby": "0"}, {"bib": {"title": "Doxorubicin and NF-kB inhibitors sensitize multiple myeloma cells to trail induced apoptosis.", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:LjlpjdlvIbIC", "citedby": "0"}, {"bib": {"title": "Targeting the molecular target of rapamycin (mTOR).", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:gVv57TyPmFsC", "citedby": "0"}, {"bib": {"title": "Regular Articles-Endocrinology-Thyroid Carcinoma Cells Are Resistant to FAS-mediated Apoptosis But Sensitive to Tumor Necrosis Factor-related Apoptosis-inducing Ligand", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:bnK-pcrLprsC", "citedby": "0"}, {"bib": {"title": "Apoptosis and the pathogenesis of Hashimoto's thyroiditis", "year": "2000"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:K3LRdlH-MEoC", "citedby": "0"}, {"bib": {"title": "Tumors of the Ewing's sarcoma family (ESF) express functional Fas ligand (FASL).", "year": "1998"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:tzM49s52ZIMC", "citedby": "0"}, {"bib": {"title": "CLINICAL AND LABORATORY INVESTIGATIONS-Skin Manifestations of Cushing Disease in Children and Adolescents Before and After the Resolution of Hypercortisolemia", "year": "1998"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:mvPsJ3kp5DgC", "citedby": "0"}, {"bib": {"title": "Volume 31-No. 3-March 2020"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:7Hz3ACDFbsoC", "citedby": "0"}, {"bib": {"title": "EXTENDED RITUXIMAB THERAPY IS HIGHLY ACTIVE IN LYMPHOPLASMACYTIC LYMPHOMA (WALDENSTROM'S MACROGLOBULINEMIA, WM) INDEPENDENT OF COMPLEMENT RESISTANCE ANTIGEN EXPRESSION."}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:cK4Rrx0J3m0C", "citedby": "0"}, {"bib": {"title": "THE HISTONE DEACETYLASE INHIBITOR SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) INDUCES GROWTH ARREST AND APOPTOSIS IN B-CELL MALIGNANCIES."}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:U4n9YNQMCAIC", "citedby": "0"}, {"bib": {"title": "THIAZOLIDINEDIONES: A NOVEL CLASS OF AGENTS WITH ACTIVITY AGAINST B-CELL MALIGNANCIES."}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:43bX7VzcjpAC", "citedby": "0"}, {"bib": {"title": "PROTEASOME INHIBITION AS A NOVEL THERAPEUTIC STRATEGY FOR WALDENSTROM'S MACROGLOBULINEMIA: CLINICAL IMPLICATIONS OF TRANSCRIPTOMIC AND CELL SIGNALING STATE (SIGNALOMIC) CHANGES \u2026"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:zCSUwVk65WsC", "citedby": "0"}, {"bib": {"title": "Anti-myeloma activity of heat shock protein-90 inhibition"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:PVgj2kMGcgYC", "citedby": "0"}, {"bib": {"title": "Our thanks to those who have helped with this issue of Expert Review of Anticancer Therapy. Listed below are the authors, referees and others who have kindly given their time \u2026"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:yFnVuubrUp4C", "citedby": "0"}, {"bib": {"title": "Our thanks to those who have helped with this issue of Expert Review of Anticancer Therapy. Listed below are the authors, referees and others who have kindly given their time \u2026"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:hCrLmN-GePgC", "citedby": "0"}, {"bib": {"title": "Molecular sequelae of histone deacetylase inhibition in human"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:q3CdL3IzO_QC", "citedby": "0"}, {"bib": {"title": "Targeting mitochondrial factor Smac/DIABLO as therapy for multiple"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:k8Z6L05lTy4C", "citedby": "0"}, {"bib": {"title": "Insights into the multistep transformation of MGUS to myeloma using"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:MLfJN-KU85MC", "citedby": "0"}, {"bib": {"title": "Our thanks to those who have helped with this issue of Expert Review of Anticancer Therapy. Listed below are the authors, referees and others who have kindly given their time \u2026"}, "source": "citations", "id_citations": "NgV8n_wAAAAJ:JoZmwDi-zQgC", "citedby": "0"}]}